Clinical trial Recruiting at 1 site Interventional Ages 18 to 55

Caudal ear nerve stimulation to test gut movement in healthy adults

Official title: The Effect of Non-invasive Transauricular Vagus Nerve Stimulation on Upper Gastrointestinal Motility in Healthy Individuals

Run by Academisch Ziekenhuis Maastricht · NCT07632378 · Data updated 2026-11-12

This study tests whether transcutaneous auricular vagus nerve stimulation can influence upper gastrointestinal movement in healthy adults who participate in a randomised, crossover setup.

More Healthy Adult Participants trials

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment12 (estimated)
SponsorAcademisch Ziekenhuis Maastricht
Academic / other
Locations1 site (Maastricht, Limburg)
StatusRecruiting
StartedFebruary 25, 2025
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedJune 8, 2026
Trial IDNCT07632378 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18-55 without GI or cardiac conditions and who can understand Dutch.

Probably not a fit

Participants with pre-existing GI disorders, cardiac arrhythmias, pregnancy, or substances affecting GI motility may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, randomized crossover trial evaluates the effects of transcutaneous auricular vagus nerve stimulation (tVNS) on upper gastrointestinal motility in healthy adults. Participants undergo 8 hours of upper GI motility recording with manometry while receiving either active tVNS or sham stimulation in random order. Secondary measures include duodenal phase III contractions, gastric and duodenal MMCs, antral contraction amplitude, motility index, motilin and peptide YY levels, autonomic markers, and comparison with Gastric Alimetry data. The study uses standard safety procedures, screening, and imaging guidance for catheter placement, with data managed in Castor EDC at Maastricht University Medical Center.

Why it matters

Potential benefit: If successful, tVNS could become a non-drug option to modulate gut motility in ways that could inform future therapies.

How similar studies have gone: Previous research on neuromodulation and GI motility shows potential but this specific tVNS and antroduodenal motility crossover approach is newer.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy participants (defined as those without a pre-existing medical comorbidity, including those without a history of cardiac arrhythmia).
* Age between 18 and 55 years.
* Ability to understand and speak the Dutch language.

Exclusion Criteria:

* Pregnancy or lactation.
* Use of any substances (such as medication or recreational drugs) influencing gastrointestinal motility
* Not meeting the inclusion criteria above.
* Students and employees of Maastricht University are not precluded from participation, unless they have a direct personal, professional of hierarchical position with regards to any of the study team members or their department.

Where it's running

  • Maastricht University
    Maastricht, Limburg, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.